Alberto Brusati
Overview
Explore the profile of Alberto Brusati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calzari L, Dragani D, Zanotti L, Inglese E, Danesi R, Cavagnola R, et al.
Clin Epigenetics
. 2024 Nov;
16(1):158.
PMID: 39543717
No abstract available.
2.
Abati E, Gagliardi D, Manini A, Del Bo R, Ronchi D, Meneri M, et al.
Brain Commun
. 2024 Sep;
6(5):fcae312.
PMID: 39315308
The gene encodes mitofusin 2, a key protein for mitochondrial fusion, transport, maintenance and cell communication. mutations are primarily linked to Charcot-Marie-Tooth disease type 2A. However, a few cases of...
3.
Casiraghi V, Milone I, Brusati A, Peverelli S, Doretti A, Poletti B, et al.
J Neurol Sci
. 2024 Sep;
466:123210.
PMID: 39241471
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative condition affecting upper and/or lower motor neurons and characterized neuropathologically by TDP-43 proteinopathy. Given its role in ALS pathobiology, it is currently...
4.
Santangelo S, Invernizzi S, Sorce M, Casiraghi V, Peverelli S, Brusati A, et al.
Hum Mol Genet
. 2024 Sep;
33(21):1900-1907.
PMID: 39222049
The hexanucleotide G4C2 repeat expansion (HRE) in C9ORF72 gene is the major cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), leading to both loss- and gain-of-function pathomechanisms. The...
5.
Calzari L, Dragani D, Zanotti L, Inglese E, Danesi R, Cavagnola R, et al.
Clin Epigenetics
. 2024 Aug;
16(1):112.
PMID: 39164752
Background: The epigenetic status of patients 6-month post-COVID-19 infection remains largely unexplored. The existence of long-COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), suggests potential long-term changes. Long-COVID includes symptoms...
6.
Maranzano A, Verde F, Dubini A, Torre S, Colombo E, Doretti A, et al.
Eur J Neurol
. 2024 Jun;
31(9):e16374.
PMID: 38853763
Objective: Little is known about amyotrophic lateral sclerosis (ALS)-nonspecific cognitive deficits - most notably memory disturbance - and their biological underpinnings. We investigated the associations of the Alzheimer's disease (AD)...
7.
Peverelli S, Brusati A, Casiraghi V, Sorce M, Invernizzi S, Santangelo S, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Dec;
25(1-2):207-210.
PMID: 38099605
The hexanucleotide repeat (HR) expansion is the main genetic cause of amyotrophic lateral sclerosis (ALS), with expansion size from 30 to >4000 units. Normal HR length is polymorphic (2-23 repeats)...
8.
Brusati A, Peverelli S, Calzari L, Tiloca C, Casiraghi V, Sorce M, et al.
Front Aging Neurosci
. 2023 Dec;
15:1272135.
PMID: 38090719
During the last decades, our knowledge about the genetic architecture of sporadic amyotrophic lateral sclerosis (sALS) has significantly increased. However, besides the recognized genetic risk factors, also the environment is...
9.
Brusati A, Agostinetto G, Bruno A, Casiraghi M, Pescini D, Sandionigi A, et al.
Methods Mol Biol
. 2023 Dec;
2732:145-154.
PMID: 38060123
Retrieval and visualization of biological data are essential for understanding complex systems. With the increasing volume of data generated from high-throughput sequencing technologies, effective and optimized data visualization tools have...
10.
Manini A, Casiraghi V, Brusati A, Maranzano A, Gentile F, Colombo E, et al.
Front Aging Neurosci
. 2023 Feb;
15:1067954.
PMID: 36819716
Background: The gene is an established susceptibility locus for amyotrophic lateral sclerosis (ALS) and a determinant of shorter survival after disease onset, with up to 33.0 months difference in life...